Laura Elizabeth Lansdowne
Managing Editor
As managing editor, Laura works closely with the editorial director to create, inform and maintain the overall editorial strategy for Technology Networks. She plays an active part in the general oversight and training of the in-house editorial team, as well as working directly with commissioned writers to produce content across the publication’s communities. After obtaining a first-class honors degree in biology, Laura worked as a quality assurance technologist before joining the Wellcome Sanger Institute and undertaking an additional qualification in clinical chemistry. In 2015, she left to pursue pharmaceutical and editorial-based roles, before joining Technology Networks in 2017.
Latest Content
Industry Insight
Women in Science: Perspectives From Industry
In honor of International Day of Women and Girls in Science 2022, Technology Networks interviewed three women who have built successful careers within the scientific industry, to learn about their career paths and the reasons they chose to work in industry.
News
Understanding Polyps and Their Colorectal Cancer Counterparts
Researchers from Vanderbilt University have discovered how polyps develop into colorectal cancer. This knowledge could help to improve how this type of cancer is monitored and treated. The study was published in Cell.
Industry Insight
Alleviating the Burden of NGS Library Preparation
Next-generation sequencing (NGS) has undoubtedly revolutionized the genomics field and thanks to technological advances in recent years, laboratories around the globe are now applying NGS to a wide variety of applications. However, library sample preparation remains a key bottleneck and researchers are now looking to adopt automation solutions to alleviate this pain point. Technology Networks recently spoke with Paul Lomax, product manager at SPT Labtech to learn more about firefly®, the company’s new liquid handling platform for NGS library preparation.
Infographic
Novel Psychoactive Substances
Novel psychoactive substances (NPS) are compounds that are designed to mimic the effects of established illicit drugs. Many NPS emerged during the early- to mid-2000s and the number of new substances being reported continues to rise. Download this infographic to explore various NPS and key characteristics, reveal why they challenge traditional approaches to drug monitoring and discover methods used to detect NPS.
Article
The Pursuit of Global, Sustainable and Cooperative Open Science
Technology Networks had the pleasure of speaking with Nobel Laureate Elizabeth Blackburn on her impressive contributions to science and society. She highlights early inspirations that cemented her love of science, elaborates on the research that led to her being co-awarded the 2009 Nobel Prize in Physiology or Medicine, and explains why she is advocating for sustainable, cooperative and open science.
News
Drug Cocktail Enables Frogs To Regenerate Amputated Limbs
Researchers have developed a multidrug-loaded wearable bioreactor that can trigger the restoration of amputated hindlimbs in adult African clawed frogs (Xenopus laevis). The animals were able to regrow and remodel a missing limb and sensorimotor function was restored.
Infographic
Milestones in Cancer Drug Discovery
Download this infographic to explore major cancer drug discovery milestones throughout history and the five pillars of modern-day cancer treatment.
Industry Insight
Developing Temperature-Stable ADDomer Vaccines for Untreatable Diseases
Technology Networks spoke with Jonathan Hare, PhD, Imophoron’s Head of Immunology, to learn more about the ADDomer™ vaccine platform, the benefits of administering vaccines by a variety of administrative routes and the infectious diseases they are currently working to develop vaccines for.
Listicle
Recent Developments in Proteomics Research
Here, we take a closer look at some recent developments in the world of proteomics research.
Podcast
Opinionated Science Episode 39: The Science of Christmas Dinner
In this bumper episode, the team review a series of studies from the last year that investigate Christmassy food. Could the future of Christmas dinner involve a cell culture roast, unnaturally smooth chocolate and fractal cauliflower?
Advertisement
